ScanSource Q1 Sales Up 30% to $962M, Raises FY27 Adjusted EBITDA Outlook to $175M-$185M
SCSC sits 64% above its 52-week low of $33.76 on elevated volume (2.7× avg).
Summary
ScanSource grew Q1 FY27 net sales 30.1% to $962.3M and raised FY27 adjusted EBITDA guidance to $175M-$185M, but gross margin fell to 12.2% and GAAP EPS dropped 53% to $0.42.
Key Events · Earnings and Guidance · SCSC
-
Q1 Sales Jump 30% to $962.3M
Net sales rose 30.1% year-over-year from $739.7M, or 26.8% on a non-GAAP basis excluding acquisitions and FX; Specialty Technology Solutions grew 28.2% to $917.3M and Intelisys & Solution Services 85.9% to $45.0M.
-
Margins Compress, GAAP EPS Halves
Gross margin fell to 12.2% from 14.5% on a hardware-heavy, lower-margin large-deal mix; GAAP diluted EPS was $0.42 versus $0.89, and non-GAAP diluted EPS $0.86 versus $1.06.
-
FY27 Outlook Raised for MicroAge
Full-year net sales guidance is now $3.8B-$4.0B (6%-10% growth) and adjusted EBITDA $175M-$185M, up from the prior $158M-$165M; free cash flow guidance held at least $85M.
-
Brazil Bad Debt Costs $0.16 Per Share
About $4.5M of higher bad debt expense, primarily on specific customer credit exposures in Brazil, reduced diluted EPS by roughly $0.16.
Analysis · SCSC · Trade & Services
Sales growth is real but bought at a price: gross margin fell 238bp to 12.2% as large, low-margin hardware deals and the newly acquired MicroAge reshaped the mix, and GAAP EPS dropped 53% to $0.42. The offsetting positive is guidance — management raised FY27 adjusted EBITDA to $175M-$185M from $158M-$165M and net sales to $3.8B-$4.0B, so the MicroAge deal is already lifting the full-year profit picture. The quarter also consumed cash: $42.3M of operating cash flow went out the door on working capital to fund the growth, and debt jumped to $332.4M from $101.4M a quarter ago to pay for the acquisition, leaving net debt at 2.0x trailing adjusted EBITDA. Add $4.5M of Brazil bad-debt expense (about $0.16 of EPS) and the quality of the beat is mixed — top line and outlook up, margins and cash conversion down.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SCSC was trading at $55.32 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $33.76 to $66.78. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.